Dextran In Carotid Endarterectomy Trial "DICE"

Recruiting

Phase N/A Results N/A

Summary of Purpose

To determine if the administration of 10% Dextran 40 during and after Carotid Endarterectomy (CEA) will reduce the risk of ipsilateral fatal and non-fatal stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 30 January 2009.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • NHMRC, Medical Specialties Australia, Pharmalink

Trial Design

Multi-centre, randomised, double blind, placebo-controlled therapeutic trial.

Contacts

  • Dennis Young Clinical Trials Manager National Stroke Research Institute Level 1, Neurosciences Bldg 300 Waterdale Road HEIDELBERG HEIGHTS VIC 3081 Ph: 613-9496-2699 Fax: 613-9496-2650

    dyoung@nsri.org.au